PROZYME Probiotics
PROZYME Probiotics
PROZYME Probiotics
Maintaining Good Health is expensive Being sick is more expensive and it leads to misery Being Healthy is the secret to Good Wealth and Good Life
Wellness Industry will become the next Trillion Dollar industry in the next five years.
3.6 million families will become new millionaires in the next five years. Paul Zane Pilzer
The Wellness Revolution
What is the cause of a disease? Disease starts from a single cell damage. Damage cells multiplies and damages the tissues, the organs and the body. What causes cell damage? * Pollution * Chemicals * Free Radicals * Bad Bacteria We cannot avoid cell damage. But we can control it by strengthening the cells to regenerate more healthy cells. How?
Right Nutrition There are 45 known essential nutrients in specific amounts needed by our body to function properly.
Our body also need carbohydrates, fats (lipids), complete proteins, water, at least 13 vitamins and 20 minerals for proper metabolic functions.
FOOD ENZYMES exist naturally in raw food but is destroyed by cooking. Our body produces Enzymes but we lose them through sweat and body waste and we use them as we live. As we age, we produce lesser enzymes and enzymes lose their strength and ability to do their work.
Environmental pollution, overly processed foods, genetically modified food, and microwave cooking result in free radical damage that lowers the body's ability to produce enzymes.
The more we depend on our internally generated ENZYMES the more stress we put on our body. Aging and other diseases manifest the low enzyme level in our body.
FACTS:
Every meal: we absorb
But many people do not even move their bowel once a day!
movements everyday!
a dietary Probiotic Health Drink formulated to support the immune system and regulate bodily functions.
These essential nutrients were derived from Mangosteen, Grapes, Guyabano, Pineapple, Papaya, Banana, Apple, Calamansi, Dalandan, Sugarcane, Malunggay, Tomato and Honey.
FIBRINOLYTIC ENZYMES - digest fibers and can dissolve the fibrin that covers tumours
Nourishes
References
Havenaar, R. (1999). The model selection tool. Dairy Industries International, 64 (6): 33-36. Havenaar, R. and Minekus, M. (1996). Simulated assimilation. Dairy Industries International 61(9): 17-23. Havenaar, R., Minekus, M. and Speckmann, A. (1995). Efficacy of Natuphos phytase in a dynamic computer-controlled model of the gastro-intestinal tract. Proceedings European Symposium on Feed Enzymes, Noordwijkerhout, Netherlands. pp 211-212. Krul, C., Humblot, C., Philippe, C., Vermeulen, M., Van Nuenen, M., Havenaar, R., Rabot, 5. (2002). metabolism of sinigrin (2- propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model. Carcinogenesis 23:1009-1016. Krul, C., Luiten-Schuite, A., Tenfelde, A., Van Ommen, B., Verhagen, H. and Havenaar, R. (2001). Antimutagenic activity of green tea and black tea extracts studied in a dynamic in vitro gastrointestinal model. Mutation Research; 474: 71-85. Krul, C., Luiten-Schuite, A., Baan, R., Verhagen, H., Mohn, G., Feron, V., and Havenaar, R. (2000). Application of a dynamic in vitro gastrointestinal tract model to study the Availability of food mutagens, using heterocyclic aromatic amines as model compounds. Food and Chemical Toxicology 38: 783-792. Larsson, M., Minekus, M., and Havenaar, R. (1997). Estimation of the bioavailability of iron and phosphorus in cereals using a dynamic in-vitro gastrointestinal model. J. Sci. Food Agric. 73: 99-106. Marteau, P., Minekus, M., Havenaar, R. and Huis in 't Veld, J.H.J. (1997). Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: Validation and the effects of bile. J. Dairy Sci. 80: 1031-1037. Minekus, M. (1998). Development and validation of a dynamic model of the gastrointestinal tract. PhD Thesis, University of Utrecht; Elinkwijk b.v., Utrecht, Netherlands. Minekus, M., Marteau, P., Havenaar, R. and Huis in 't Veld, J.H.J. (1995). A multi compartmental dynamic computercontrolled model simulating the stomach and small intestine. Alternatives to Laboratory Animals (ATLA) 23: 197-209. Minekus, M., Smeets-Peeters, M., Bernalier, A., Marol-Bonnin, S., Havenaar, R., Marteau, P., Airic, M., Fonty, G., and Huis in 't Veld, J.H.J. (1999). A computer controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl. Microb. Biotechn. 53: 108-114. Minekus, M. and Havenaar, R. (1996). In vitro model of an in vivo digestive tract. United States Patent; nr. 5,525,305, dated June 11, 1996. Minekus, M. and Havenaar, R. (1998). Reactor system. European Patent No. 0642382. Eur. Patent Bulletin 98/07, Art. 97(4) and (5) EPC, dated 11.02.98.
Smeets-Peeters, M.J.E. (2000). Feeding FIDO: Development, validation and application of a dynamic in vitro model of the gastrointestinal tract of the dog. PhD Thesis Wageningen University. Universal Press, Veenendaal, The Netherlands. Smeets-Peeters, M.J.E., Minekus, M., Havenaar, R., Schaafsma, G., Verstegen, M.W.A. (1999a). Description of a dynamic in vitro model of the dog gastrointestinal tract and an evaluation of various transit times for protein and calcium. ATLA 27: 935-949. Smeets-Peeters, M., Havenaar, R., Schaafsma, G. and Verstegen, M. (1999b). Validation of a dynamic computercontrolled in vitro model of the canine gastrointestinal tract. In: Proceedings World Congress on Alternatives to Laboratory Animal Science, Bologna, Italy. Smeets-Peeters, M, Watson, T., Minekus, M., Havenaar, R. (1998). A review of the physiology of the canine digestive tract related to the Development of in vitro systems. Nutrition Research Reviews 11: 45-69. Venema, K., Van Nuenen, M., Smeets-Peeters, M., Minekus, M. and Havenaar, R. (2000). TNO's in vitro large intestinal model: an excellent screeening tool for functional food and pharmaceutical Research. ErnahrungfNutrition 24 (12): 558-564. Zeijdner, E. and Havenaar, R. (2000). The fate of orally administrated compounds during passage through the gastrointestinal tract simulated in a dynamic in vitro model (TIM). European pharmaceutical Contractor, Febr. isue: 76-81. Zeijdner, E.E. and Mohede, I.C.M. (1999). Latest tool for screening new clinical foods. A dynamic, computer-controlled model of the human gastrointestinal tract is the most up-to-date technology for testing new foods. New World Health 1999/2000: 105.a Arkbge, K., Verwei, M., Havenaar, R., Witthft, C. (2003). Folic acid and (6S)-5-methyltetrahydrofolate bioaccessibility decreases after addition of folate-binding protein to yogurt as studied in a dynamic in vitro gastrointestinal model. J. Nutr. 133: 3678-3683. Verwei, M., Arkbge, K., Havenaar, R., Van den Berg, H., Witthft, C. and Schaafsma, G. (2003). Folic acid and 5Methyltetrahydrofolate in fortified milk are bioaccessible as determined in a dynamic in vitro gastrointestinal model. J. Nutr. 133: 2377-2383. Verwei, M., Arkbge, K., Mocking, H., Havenaar, R. and Groten, J. (2004). The binding of folic acid and 5methyltetrahydrofolate to folate-binding proteins during gastric passage differs in a dynamic in vitro gastrointestinal model. J. Nutr. 134: 31-37. Van Nuenen, H.M.C., Meyer, P.D., Venema, K. (2003). The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microbial Ecology in Health and Disease 15 (2-3): 137-144. Venema, K. Van Nuenen, H.M.C., Van den Heuvel, E.G., Pool, W., Van der Vossen, J.M.B.M. (2003).The effect of lactulose on the composition of the intestinal microbiota and short-chain fatty acid production in human volunteers and a computer-controlled modelof the proximal large intestine. Microbial Ecology in Health and Disease, 15 (2-3): 94-105.
Thank You...